Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning
Neuro-Oncology · 05.01.2023 · 25 (1) · 68-81
DOI: 10.1093/neuonc/noac154 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neuro-Oncology, online erschienen am 18.06.2022. Verfasst von Xiao-Ping Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, National Institutes of Health.
Abstract (Originalsprache)
Background
Lower-grade gliomas (LGG) are heterogeneous diseases by clinical, histological, and molecular criteria. We aimed to personalize the diagnosis and therapy of LGG patients by developing and validating robust cellular morphometric subtypes (CMS) and to uncover the molecular signatures underlying these subtypes.
Methods
Cellular morphometric biomarkers (CMBs) were identified with artificial intelligence technique from TCGA-LGG cohort. Consensus clustering was used to define CMS. Survival analysis was performed to assess the clinical impact of CMBs and CMS. A nomogram was constructed to predict 3- and 5-year overall survival (OS) of LGG patients. Tumor mutational burden (TMB) and immune cell infiltration between subtypes were analyzed using the Mann-Whitney U test. The double-blinded validation for important immunotherapy-related biomarkers was executed using immunohistochemistry (IHC).
Results
We developed a machine learning (ML) pipeline to extract CMBs from whole-slide images of tissue histology; identifying and externally validating robust CMS of LGGs in multicenter cohorts. The subtypes had independent predicted OS across all three independent cohorts. In the TCGA-LGG cohort, patients within the poor-prognosis subtype responded poorly to primary and follow-up therapies. LGGs within the poor-prognosis subtype were characterized by high mutational burden, high frequencies of copy number alterations, and high levels of tumor-infiltrating lymphocytes and immune checkpoint genes. Higher levels of PD-1/PD-L1/CTLA-4 were confirmed by IHC staining. In addition, the subtypes learned from LGG demonstrate translational impact on glioblastoma (GBM).
Conclusions
We developed and validated a framework (CMS-ML) for CMS discovery in LGG associated with specific molecular alterations, immune microenvironment, prognosis, and treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
- Berkeley Biomedical Data Science Center, Lawrence Berkeley National Laboratory, Berkeley, California, USA.
- Department of Emergency, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
- Department of Pathology, Stanford University Medical Center, Stanford, California, USA.
- Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
ORCID-Profile: Yankai Xia, Paul J van Diest, Hang Chang
Förderung
- NCI NIH HHS
- National Cancer Institute
- National Institutes of Health
- Zhongnan Hospital of Wuhan University
Zitieren
APA
Liu, X. P., Jin, X., Seyed Ahmadian, S., Yang, X., Tian, S. F., Cai, Y. X., Chawla, K., Snijders, A. M., Xia, Y., van Diest, P. J., Weiss, W. A., Mao, J. H., Li, Z. Q., Vogel, H., & Chang, H. (2023). Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning. Neuro-Oncology, 25(1), 68-81. https://doi.org/10.1093/neuonc/noac154
Vancouver
Liu XP, Jin X, Seyed Ahmadian S, Yang X, Tian SF, Cai YX, et al. Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning. Neuro-Oncology. 2023;25(1):68-81. doi:10.1093/neuonc/noac154
BibTeX
@article{Liu2023,
author = {Liu, Xiao-Ping and Jin, Xiaoqing and Seyed Ahmadian, Saman and Yang, Xu and Tian, Su-Fang and Cai, Yu-Xiang and Chawla, Kuldeep and Snijders, Antoine M and Xia, Yankai and van Diest, Paul J and Weiss, William A and Mao, Jian-Hua and Li, Zhi-Qiang and Vogel, Hannes and Chang, Hang},
title = {Clinical significance and molecular annotation of cellular morphometric subtypes in lower-grade gliomas discovered by machine learning},
journal = {Neuro-Oncology},
year = {2023},
volume = {25},
number = {1},
pages = {68--81},
doi = {10.1093/neuonc/noac154}
}
EUVIMED